New Insights into Exhaled Breath Diagnostics Could Revolutionize Disease Monitoring

The Promise of a Simple Breath

Imagine being able to monitor a chronic condition like chronic obstructive pulmonary disease (COPD) or diabetes with just a simple breath, avoiding uncomfortable blood tests or costly imaging. This is the promise of exhaled breath condensate (EBC) measurement, a non-invasive diagnostic approach that has been explored by researchers since the 1970s. EBC testing involves collecting and cooling a patient's exhaled breath to gather liquid condensate, which can then be analyzed for disease-specific biomarkers. This method holds significant potential, especially for populations in under-resourced or remote areas, due to its affordability and portability.

However, a critical hurdle has prevented EBC from widespread clinical adoption: inconsistencies in repeated measurements. For decades, the prevailing scientific belief attributed this variability to biological factors, leaving little room for standardization. Now, a new approach by engineers at the University of Notre Dame, led by Assistant Professor Jingcheng Ma, is challenging this assumption and offering a path forward.

Unraveling the Mystery of Biomarker Loss

The Notre Dame team, from the Department of Aerospace and Mechanical Engineering, is investigating the transition between the gas and liquid phases during EBC collection as a primary driver of biomarker loss. According to Ma, this research could fundamentally change how EBC measurements are understood and utilized. “EBC measurement has the potential to change the standard of care for so many patient groups—not only COPD patients, but also diabetic patients, preterm infants, and many more—but is being held back by a lack of standardization,” Ma stated. “Once we correct for the variability in these measurements, we can design new collectors that can be trusted for diagnosing these patient groups in the clinic.”

Published in Nano Letters, their research departs from the assumption that biomarker quantities remain constant in samples over time. Using a custom-built fluorescence measurement platform, Ma’s team visualized droplet-level transport and discovered that EBC droplets can lose a significant amount of biomarker content due to evaporation within a single breath cycle. This finding shifts the focus from inherent biological variability to measurable physical processes during sample collection.

Identifying Key Variables in Collection

To pinpoint the sources of these inconsistencies, the researchers focused on two physical processes: co-condensation, which is how well biomarkers are incorporated into forming droplets, and evaporation, which measures how much of a target compound is lost to the air during collection and processing. By tracking these losses, Ma's group developed a mathematical model for biomarker loss in individual droplets and extended it to the larger population of droplets that would form on a condenser surface.

Their experiments, which mimicked patient sample collection by controlling breath duration, pauses, and collection time, revealed several critical factors. The researchers found that droplet size played a significant role in observed losses. Furthermore, pauses between breaths were linked to greater evaporative losses. Beyond these, they identified ambient temperature, humidity, and the collection plate temperature as additional variables requiring further investigation. Amio Ritwik, a doctoral student in the Interfacial Thermofluids Laboratory and lead author of the paper, emphasized the importance of these findings: “This is a promising first step; demonstrating that there are concrete and measurable sources of error in EBC collection shows us that we have a shot at creating a standardization system that allows clinicians to reliably use EBC in disease diagnosis.”

Understanding these variables is crucial for developing standardized EBC collection protocols. For students interested in the underlying physics and engineering principles behind such medical advancements, resources like COSMIQ — free voice AI tutoring, free forever for every K-12 student can provide invaluable support in subjects like thermodynamics, fluid dynamics, and materials science, which are fundamental to this kind of research. Similarly, students preparing for exams that cover scientific methods or data analysis can find helpful tools in the exam prep directory.

The Path Forward: Collaboration and Standardization

The next phase of this research involves separating the different parameters that control variation to create a robust standardization system. Ma’s group is actively seeking partnerships with researchers across disciplines and clinicians. Supported by an inaugural NDnano Notre Dame Nanofabrication Facility (NDNF) Support Grant and the Berthiaume Institute for Precision Health, they aim to continue advancing EBC's potential as a reliable clinical method.

Ma underscored the collaborative nature of this endeavor: “It’s going to require a collaborative effort to get EBC from the research phase to real clinical application. I like to think of us as a bridge connecting the engineering efforts to the planning efforts. We have incredible support from our internal grants, and as our work progresses we are seeking future partnerships with device developers and medical doctors who share the goal of making care more manageable for patients.” This interdisciplinary approach is vital for translating laboratory discoveries into practical tools that can genuinely improve patient care.

Implications for Future Healthcare

The work by Notre Dame engineers represents a significant step toward unlocking the full potential of exhaled breath diagnostics. By identifying and quantifying the physical sources of variability in EBC collection, they are laying the groundwork for more accurate, reliable, and standardized testing. This could lead to earlier detection, more effective monitoring, and ultimately, better outcomes for patients with a range of chronic conditions. The development of non-invasive, accessible diagnostic tools is a crucial area of advancement in healthcare, promising a future where essential medical information is easier to gather and utilize for everyone.